[Experimental and clinical pharmacological aspects of the hallucinogen LSD-25].
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001921:Brain / Q000378:metabolism; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology* / Q000633:toxicity; D001523:Mental Disorders / Q000188:drug therapy; D008606:Mental Processes / Q000187:drug effects; D009420:Nervous System / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism
D012701:Serotonin; D008238:Lysergic Acid Diethylamide
Aspetti di farmacologia sperimentale e clinica dell'allucinogeno LSD-25.